EphA2-positive human umbilical cord-derived mesenchymal stem cells exert anti-fibrosis and immunomodulatory activities via secretion of prostaglandin E2
Objective: Previous study has demonstrated that EphA2 is a biomarker of mesenchymal stem cells (MSCs) from human placenta or umbilical cord and is able to distinguish MSCs from fibroblasts. In this study, we further examine the potential efficacy of EphA2+ human umbilical cord-derived MSCs (hUC-MSCs...
Saved in:
Main Authors: | Yu-Chieh Wen (Author), Mao-Kuang Du (Author), Meng-Wei Li (Author), Yogi Cheng-Yo Hsuan (Author), Yu-Chin Su (Author), Willie Lin (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EphA2 is a biomarker of hMSCs derived from human placenta and umbilical cord
by: Shih-Pei Shen, et al.
Published: (2015) -
Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2)
by: Theodore J. Kottom, et al.
Published: (2024) -
Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents
by: Ahmed F. Salem, et al.
Published: (2020) -
A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-κB Signaling Pathways
by: Li Zeng, et al.
Published: (2018) -
COE targets EphA2 to inhibit vasculogenic mimicry formation induced by hypoxia in hepatocellular carcinoma
by: Jue Chen, et al.
Published: (2024)